Portfolio company Ceribell targeted a $578.3M valuation in its upsized IPO.
Ceribell is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions through its innovative point-of-care EEG platform
Ceribell is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions through its innovative point-of-care EEG platform.